Daiane Keller Cecconello
Overview
Explore the profile of Daiane Keller Cecconello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cecconello D, Silva K, de Senna E, Rechenmacher C, Daudt L, Michalowski M
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339172
Acute lymphoblastic leukemia represents the most prevalent childhood cancer. Modern chemotherapy has significantly improved outcomes, achieving EFS rates of 80% and OS rates nearing 90% in developed nations, while in...
2.
Silva K, Magalhaes I, Benincasa D, Cecconello D, Michalowski M
Cancer Rep (Hoboken)
. 2024 Aug;
7(8):e2142.
PMID: 39190425
Background: Langerhans cell histiocytosis (LCH) is a clonal myeloid neoplasm with inflammatory component. Refractory disease is a challenge, but vemurafenib has emerged as a therapeutic option. We will delineate the...
3.
Cecconello D, Spagnol F, Alegretti A, Pilger D, Farias M
Hematol Transfus Cell Ther
. 2023 Aug;
46 Suppl 5:S136-S142.
PMID: 37652805
Introduction And Objective: Flow Cytometry (FC) is one of the techniques, which allows the identification and characterization of platelets. The detection of absent or reduced expression of the glycoproteins is...
4.
Cecconello D, Rechenmacher C, Silva K, Scherer F, Prates T, Marques R, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):86.
PMID: 36333762
Acute lymphoblastic leukemia is the most common childhood malignancy. One of the drugs used in the treatment is Asparaginase, and monitoring of its activity levels enables better outcomes. Since 2018,...
5.
Michalowski M, Cecconello D
Pediatr Blood Cancer
. 2021 Aug;
68(11):e29294.
PMID: 34390162
No abstract available.
6.
Michalowski M, Cecconello D, Lins M, Carvalho M, Silva K, Cristofani L, et al.
Br J Haematol
. 2021 May;
194(1):168-173.
PMID: 33993488
Our group recently showed that the (ASNase) formulation available in Brazil from 2017 to 2018 when used at the same dose and frequency as the formulation provided previously did not...
7.
Cecconello D, Rechenmacher C, Werlang I, Zenatti P, Yunes J, Alegretti A, et al.
Sci Rep
. 2020 Dec;
10(1):21481.
PMID: 33293625
Acute lymphoid leukemia is a childhood cancer that in high-income countries has event-free survival rates of 80% and global survival rates of 90%. In Brazil these rates are under 70%....
8.
Cecconello D, de Magalhaes M, Ribas Werlang I, de Martino Lee M, Michalowski M, Daudt L
Hematol Transfus Cell Ther
. 2019 Dec;
42(3):275-282.
PMID: 31801703
The long-term outcome of acute lymphoblastic leukemia has improved dramatically due to the development of more effective treatment strategies. L-asparaginase (ASNase) is one of the main drugs used and causes...
9.
Cecconello D, Ribas Werlang I, Alegretti A, Hahn M, de Magalhaes M, Battistel A, et al.
Lancet Oncol
. 2018 Aug;
19(9):1149-1150.
PMID: 30078698
No abstract available.